bw 737c89 has been researched along with ecopipam in 2 studies
| Studies (bw 737c89) | Trials (bw 737c89) | Recent Studies (post-2010) (bw 737c89) | Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 147 | 18 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daly, SA; Waddington, JL | 1 |
| Bergman, J; Rosenzweig-Lipson, S | 1 |
2 other study(ies) available for bw 737c89 and ecopipam
| Article | Year |
|---|---|
Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Isoquinolines; Male; Papaverine; Phenethylamines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrahydroisoquinolines | 1992 |
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Isoquinolines; Male; Receptors, Dopamine D1; Saimiri; Tetrahydroisoquinolines | 1994 |